Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06629246
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-09-23
Brief Title:
Pogejiuxin Decoction Combination of Conventional Western Medicine for the Treatment of Heart Failure with Preserved Ejection Fraction
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Randomized Controlled Trial to Evaluate the Efficacy and Safety of Pogejiuxin Decoction Combination of Conventional Treatment for Heart Failure with Preserved Ejection FractionHFpEF
Status:
COMPLETED
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of this study is to investigate the potential of Pogejiuxin Decoction to enhance the efficacy and mitigate the adverse effects associated with conventional treatment in patients with heart failure and preserved ejection fractionHFpEF thereby establishing a foundation for its clinical application in managing HFpEF
Detailed Description:
This study recruits patients with heart failure and preserved ejection fractionHFpEF randomly assigning them to either the intervention group or the control group The control group will receive the standard heart failure treatment protocol while the intervention group will take Pogejiuxin Decoction orally in addition to the control groupamp39s treatment The study will compare the degree of symptom improvement relevant auxiliary examination indicators traditional Chinese medicine syndrome scores and adverse reaction differences between the two groups providing a clinical basis for the further enhancement of HFpEF treatment with the combination of Pogejiuxin Decoction and conventional therapy
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None